These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10155050)

  • 1. Retrospective study of bitolterol mesylate in the treatment of conditions associated with reversible bronchospasm.
    Messina MS
    Adv Ther; 1995; 12(3):157-63. PubMed ID: 10155050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol.
    Kemp JP; Orgel HA; Grossman J; Reed CE; Tinkelman DG; Webb DR; Ziment I
    Ann Allergy; 1987 Jul; 59(1):17-20. PubMed ID: 3300436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.
    Nathan RA; Bronsky EA; Dockhorn RJ; Kemp JP
    Ann Allergy; 1994 Mar; 72(3):209-16. PubMed ID: 8129213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of inhaled metaproterenol via metered-dose and hand-held nebulization in prehospital treatment of bronchospasm.
    Rottman SJ; Robinson NE; Birnbaum ML
    Prehosp Disaster Med; 1996; 11(4):280-4. PubMed ID: 10163609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of inhaled bitolterol mesylate via metered-dose inhaler in children with asthma.
    Bierman CW; Kemp JP; Nathan RA
    Ann Allergy Asthma Immunol; 1996 Jan; 76(1):27-35. PubMed ID: 8564625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.
    Pinnas JL; Bhatt BD; Campbell SC; Kemp JP; Tinkelman DG
    Chest; 1987 Apr; 91(4):533-9. PubMed ID: 3549173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of bronchospasm in impairment of bronchial permeability in bronchial asthma in attack-free period].
    Nefedov VB; Popova LA
    Klin Med (Mosk); 1999; 77(12):30-3. PubMed ID: 10684212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle-size distribution of bitolterol mesylate solution delivered by four compressed-air nebulizer devices.
    Hunke WA; Yu AB
    Am J Hosp Pharm; 1987 Jun; 44(6):1392-6. PubMed ID: 3618619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.
    Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P
    Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of bronchospasm in development of bronchial obstruction in chronic bronchitis].
    Nefedov VB; Shergina EA
    Ter Arkh; 2000; 72(11):57-9. PubMed ID: 11229314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low incidence of paradoxical bronchoconstriction in asthma and COPD patients during chronic use of Respimat soft mist inhaler.
    Hodder R; Pavia D; Dewberry H; Alexander K; Iacono P; Ponitz H; Beck E
    Respir Med; 2005 Sep; 99(9):1087-95. PubMed ID: 15893465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
    Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH
    Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of ipratropium bromide in the recovery phase of methacholine induced-bronchospasm.
    Sposato B; Mariotta S; Ricci A; Bruno P; Terzano C; Mannino F
    Eur Rev Med Pharmacol Sci; 2005; 9(2):117-23. PubMed ID: 15945501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrbuterol: a new bronchodilator. Phase I-single dose study.
    Steen SN; Ziment I; Thomas JS
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1077-81. PubMed ID: 4215618
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy.
    Tashkin DP; Klein GL; Colman SS; Zayed H; Schonfeld WH
    Am J Med; 2007 May; 120(5):435-41. PubMed ID: 17466655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the bronchodilator effect of salbutamol between pressure metered dosed inhaler and dry powder inhaler in patients with stable bronchial asthma].
    Yoshimi Y; Fujimura M; Yasui M; Kasahara K; Nakao S
    Arerugi; 2004 May; 53(5):502-7. PubMed ID: 15247530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results from comparative study of the bronchodilator effect of decloxizine in patients with reversible bronchospasm].
    Hrouda J; Bogaard JM
    Acta Tuberc Pneumol Belg; 1968; 59(4):742-8. PubMed ID: 5739760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.